Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person3
Neil Peter Record
Person
RECORD PLC
Company · 01927640
Riley Corey Neil
Company
Primary record20
Bluejay Diagnostics, Inc. filed 8-K
Item 3.03 Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information regarding the Reverse Stock Split (as defined herein) contained in Item 5.03 of this Current
fca_pdmr_buy
National Storage Mechanism | Additional information RNS Number : 4949B Duke Capital Limited 03 November 2026 3 November 2026 Duke Capital Limited ("Duke Capital", "Duke" or the "Company") Director Share Purchases Duke Ca
Quoin Pharmaceuticals Ltd. filed SCHEDULE 13G/A
(the "SEC") on September 25, 2026. Neil Shahrestani b X1 0.00 211538.00 0.00 211538.00 211538.00 N 4.4 HC IN (1) The figures in Items 6, 8, and 9 represent American Depositary Shares, each representing thirty-five (35) O
SUBIN NEIL S filed SCHEDULE 13D/A
on Form 6-K ("Form 6-K") as filed with the U.S. Securities and Exchange Commission on December 5, 2025). 0001728825 N MILFAM LLC a AF PF OO N DE 0.00 1957597.00 0.00 1957597.00 1957597.00 N 12.9 OO Note to Rows 8, 10 and
Corbus Pharmaceuticals Holdings, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On September 14, 2026, Corbus Pharmaceuticals Holdings, Inc. (the Company ) issued a press release announcing positive topline data from its CANYON-1 Phase 1b clinical trial of CRB-913
ESPEY MFG & ELECTRONICS CORP filed 8-K
ITEM 8.01 Other Events On September 8, 2026 Espey Mfg. & Electronics Corp. issued a press release announcing that the Company's Board of Directors had declared a special cash dividend of $0.75 per share. This special div
Ikarian Capital, LLC filed SCHEDULE 13G/A
(the "SEC") on December 19, 2025. Neil Shahrestani b X1 0 575778 0 575778 575778 N 4.9 IN HC (1) The figures in Items 6, 8, and 9 represent American Depository Shares of the Issuer that may be acquired by Ikarian Healthc
Blumenthal Neil Harris filed SCHEDULE 13G/A
0001104659-26-097119.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001883345 XXXXXXXX LIVE 3 Class A Common Stock, par value $0.0001 per share ("Class A Common"). 06/30/2026 0001504776 Warby Parke
Ikarian Capital, LLC filed SCHEDULE 13G/A
(the "SEC") on August 14, 2026. Neil Shahrestani b X1 0 1555423 0 1555423 1555423 N 9.5 IN HC (1) The figures in Items 6, 8, and 9 represent Common Stock of the Issuer held by the Fund and certain separately managed acco
CNS Pharmaceuticals, Inc. filed SCHEDULE 13G/A
(the "SEC") on August 12, 2026. Neil Shahrestani b X1 0 147290 0 147290 147290 N 9.9 IN HC (1) The figures in Items 6, 8, and 9 represent Common Stock of the Issuer held by the Fund and certain separately managed account
Connect Biopharma Holdings Ltd filed SCHEDULE 13G/A
(the "SEC") on August 12, 2026. Neil Shahrestani b X1 0 4338534 0 4338534 4338534 N 6.9 IN HC (1) The figures in Items 6, 8, and 9 represent Ordinary Shares of the Issuer held by the Fund and certain separately managed a
Ikarian Capital, LLC filed SCHEDULE 13G
(the "SEC") on May 6, 2026. Neil Shahrestani b X1 0 137634 0 137634 137634 N 4.2 IN HC (1) The figures in Items 6, 8, and 9 represent Common Shares of the Issuer held by the Fund and certain separately managed accounts.
Ikarian Capital, LLC filed SCHEDULE 13G/A
(the "SEC") on August 6, 2026. Neil Shahrestani b X1 0 502672 0 502672 502672 N 9.99 IN HC (1) The figures in Items 6, 8, 9, and 11 represent Common Stock of the Issuer held by the Fund and certain separately managed acc
Galera Therapeutics, Inc. filed SCHEDULE 13G/A
0001193125-26-352953.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001778253 XXXXXXXX LIVE 1 Common Stock, $0.001 par value per share 06/30/2026 0001563577 Galera Therapeutics, Inc. 36338D108 101
Ikarian Capital, LLC filed SCHEDULE 13G
(the "SEC") on July 31, 2026. Neil Shahrestani b X1 0 91789 0 91789 91789 N 9.0 IN HC (1) The figures in Items 6, 8, and 9 represent Common Stock of the Issuer held by the Fund and certain separately managed accounts. Se
Ikarian Capital, LLC filed SCHEDULE 13G/A
(the "SEC") on July 31, 2026. Neil Shahrestani b X1 0 1080700 0 1080700 1080700 N 2.9 IN HC (1) The figures in Items 6, 8, and 9 represent Common Stock of the Issuer held by the Fund and certain separately managed accoun
Zeo Energy Corp. filed 8-K
Item 5.07 Submission of Matters Vote of Security Holders On August 7, 2026, Zeo Energy Corp. (the “Company”) conducted its 2026 annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, 35,399,972 sha
David Davis (Conservative) registered £5,000 from Neil Record
Neil Record - £5,000.00. Donations and other support (including loans) for activities as an MP. Conservative, Goole and Pocklington. Donor status: Individual. Received 2026-06-10
The Rt Hon David Davis MP accepted £5,000.00 from Neil Record
The Rt Hon David Davis MP reported accepting £5,000.00 from Neil Record. Donor status: Individual. Type: Non Cash. Accepted 10/06/2026.
Conservative and Unionist Party accepted £50,000.00 from Neil Peter Record
Conservative and Unionist Party reported accepting £50,000.00 from Neil Peter Record. Donor status: Individual. Type: Cash. Accepted 11/03/2026.